A short review on scenario of Type 1 diabetes in Australia

Authors

  • Nalini Kanta Sahoo Department of PA and QA, Marri Laxman Reddy (MLR) Institute of Pharmacy, Dundigal, Medchal, Telangana, Hyderabad, Telangana, India
  • K.S. Murali Krishna Department of PA and QA, Marri Laxman Reddy (MLR) Institute of Pharmacy, Dundigal, Medchal, Telangana, Hyderabad, Telangana, India
  • Madhusmita Sahu Department of PA and QA, Marri Laxman Reddy (MLR) Institute of Pharmacy, Dundigal, Medchal, Telangana, Hyderabad, Telangana, India

DOI:

https://doi.org/10.37591/rrjoi.v9i2.1622

Abstract

Type 1 diabetes (T1D) is caused by an autoimmune attack on pancreatic beta cells that leads to insulin deficiency. The incidence of T1D in Australia has doubled over the past 20 years. T1D treatment focuses on physiological insulin replacement, aiming for near-normal blood glucose levels. Morbidity and mortality result in hypoglycemia in T1D. Better results can be achieved by following some of the new technologies which includes insulin pumps, continuous glucose monitoring, sensor augmented pumps etc. and can ultimately reduce the risk of severe hypoglycemia. Pregnant women can be benefited for their infants by following intensive glycaemic control.

 

Keywords: Hypoglycemia, auto immune attack, type 1 diabetes (T1D).

Cite this Article

Nalini Kanta Sahoo, K.S. Murali Krishna, Madhusmita Sahu. A Short Review on Scenario of Type 1 Diabetes in Australia. Research & Reviews: A Journal of Immunology. 2019; 9(2): 1–5p.

Downloads

Published

2019-08-26

Issue

Vol. 9 No. 2 (2019)

Section

Review Article

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  •  I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

4. ________________

 

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.